In The News
Judge approves $31.5M settlement in junior doctors class action
Slashing funder’s stolen wages cut could deter public interest cases, court told
Law firm files first class action over Google’s ad tech dominance
Landmark $50M settlement over Meta’s Cambridge Analytica scandal
Qantas to pay $120M to settle ground crew outsourcing case
Westpac shouldn’t mediate employee suit with ‘one hand behind back’: court
Active Super says ASIC penalty would fall on ‘poor old members’
Ex-EY partner’s reputation ‘only thing of value to him’, court told
Justice Richard Niall appointed to lead Victorian Supreme Court
AUSTRAC accuses online betting firm Entain of money laundering failures
Please login to bookmarkClose

AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au